Study on growth problems in the womb linked to blood flow issues
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study follows women whose babies have a growth problem in the womb (FGR) linked to how blood flows to the placenta. It looks at causes and outcomes to help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with one baby.
- Your baby has been diagnosed with a growth problem (FGR) based on specific guidelines.
- You are willing to sign a consent form to join.
- Your baby does not have a known genetic disorder, serious infection, or major birth defect.
- You have all the needed medical information available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether melatonin (a natural sleep hormone) can help babies who are not growing well in the womb due to placental blood-flow problems. Researchers will measure if melatonin improves the baby's growth and health before delivery.
This study aims to better predict fetal growth restriction (when a baby doesn't grow as expected) in women who have certain risk factors. By joining, you may help doctors develop better screening tools for future pregnancies.
This study uses artificial intelligence (AI) to analyze ultrasound images and predict pregnancy outcomes for babies with early-onset fetal growth restriction (FGR) caused by placenta problems. If you are carrying a single baby with this condition and your doctor is continuing to monitor the pregnancy without immediate delivery, this trial may apply to you.
This study looks at babies in monochorionic (shared-placenta) twin pregnancies where one or both babies are growing too slowly. It aims to better understand this condition and follow families over time to improve care, with check-ins through age 2 after birth.
This study looks at how early, slow fetal growth is managed during pregnancy. It compares an “angiogenic factors” approach with an ultrasound (blood-flow) approach to help guide care and improve outcomes.
This study uses ultrasound to look at blood flow patterns in the heart and major blood vessels of babies who are smaller than expected (fetal growth restriction). It will compare these patterns to those in normally growing babies to see how they change as other growth measurements change.
Hear when a new MVM-FGR trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.